Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4210630
Max Phase: Preclinical
Molecular Formula: C45H39F4N7O8S
Molecular Weight: 913.91
Molecule Type: Small molecule
Associated Items:
ID: ALA4210630
Max Phase: Preclinical
Molecular Formula: C45H39F4N7O8S
Molecular Weight: 913.91
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(O)c1cn(C2CC2)c2cc(N3CCN(c4nc(N5CCN(c6cc7c(cc6F)c(=O)c(C(=O)O)cn7C6CC6)CC5)c(F)c(S(=O)(=O)c5ccccc5)c4F)CC3)c(F)cc2c1=O
Standard InChI: InChI=1S/C45H39F4N7O8S/c46-31-18-27-33(55(24-6-7-24)22-29(39(27)57)44(59)60)20-35(31)51-10-14-53(15-11-51)42-37(48)41(65(63,64)26-4-2-1-3-5-26)38(49)43(50-42)54-16-12-52(13-17-54)36-21-34-28(19-32(36)47)40(58)30(45(61)62)23-56(34)25-8-9-25/h1-5,18-25H,6-17H2,(H,59,60)(H,61,62)
Standard InChI Key: FPRXFCYDGVNBNQ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 913.91 | Molecular Weight (Monoisotopic): 913.2517 | AlogP: 5.82 | #Rotatable Bonds: 10 |
Polar Surface Area: 178.59 | Molecular Species: ACID | HBA: 13 | HBD: 2 |
#RO5 Violations: 3 | HBA (Lipinski): 15 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 5.57 | CX Basic pKa: 0.35 | CX LogP: 6.89 | CX LogD: 3.81 |
Aromatic Rings: 6 | Heavy Atoms: 65 | QED Weighted: 0.16 | Np Likeness Score: -0.64 |
1. Zhang GF, Liu X, Zhang S, Pan B, Liu ML.. (2018) Ciprofloxacin derivatives and their antibacterial activities., 146 [PMID:29407984] [10.1016/j.ejmech.2018.01.078] |
2. Chu XM, Wang C, Liu W, Liang LL, Gong KK, Zhao CY, Sun KL.. (2019) Quinoline and quinolone dimers and their biological activities: An overview., 161 [PMID:30343191] [10.1016/j.ejmech.2018.10.035] |
Source(1):